123 related articles for article (PubMed ID: 7979552)
1. Elevated levels of soluble tumour necrosis factor receptor I in blister fluids of bullous pemphigoid and suction blisters.
Zentner A; Rendl J; Grelle I; Dummer R; Bröcker EB; Zillikens D
Arch Dermatol Res; 1994; 286(6):355-7. PubMed ID: 7979552
[No Abstract] [Full Text] [Related]
2. Determination of tumor necrosis factor in blister fluids of bullous pemphigoid.
Takematsu H; Ohta H; Tagami H
Arch Dermatol Res; 1991; 283(2):131-2. PubMed ID: 2069411
[No Abstract] [Full Text] [Related]
3. Detection of IL-1 alpha, IL-1 beta and IL-1 receptor antagonist in blister fluid of bullous pemphigoid.
Schmidt E; Mittnacht A; Schömig H; Dummer R; Bröcker EB; Zillikens D
J Dermatol Sci; 1996 Feb; 11(2):142-7. PubMed ID: 8869035
[TBL] [Abstract][Full Text] [Related]
4. Elevated levels of interleukin-8 in blister fluid of bullous pemphigoid compared with suction blisters of healthy control subjects.
Schmidt E; Ambach A; Bastian B; Bröcker EB; Zillikens D
J Am Acad Dermatol; 1996 Feb; 34(2 Pt 1):310-2. PubMed ID: 8642104
[No Abstract] [Full Text] [Related]
5. The existence of a platelet-activating factor (Paf-acether)-like substance in blister fluid derived from patients with bullous pemphigoid as demonstrated by human platelet aggregation techniques.
Okubo K; Karashima T; Hachisuka H; Sasai Y
Kurume Med J; 1989; 36(4):173-9. PubMed ID: 2700767
[TBL] [Abstract][Full Text] [Related]
6. Blister fluid cytokines in cutaneous inflammatory bullous disorders.
Rhodes LE; Hashim IA; McLaughlin PJ; Friedmann PS
Acta Derm Venereol; 1999 Jul; 79(4):288-90. PubMed ID: 10429986
[TBL] [Abstract][Full Text] [Related]
7. High levels of interleukin-8, soluble CD4 and soluble CD8 in bullous pemphigoid blister fluid. The relationship between local cytokine production and lesional T-cell activities.
Sun CC; Wu J; Wong TT; Wang LF; Chuan MT
Br J Dermatol; 2000 Dec; 143(6):1235-40. PubMed ID: 11122027
[TBL] [Abstract][Full Text] [Related]
8. The autoimmune blistering skin disease bullous pemphigoid. The presence of plasmin/alpha 2-antiplasmin complexes in skin blister fluid indicates plasmin generation in lesional skin.
Kramer MD; Reinartz J
J Clin Invest; 1993 Aug; 92(2):978-83. PubMed ID: 7688770
[TBL] [Abstract][Full Text] [Related]
9. Relationship between theoretical molecular weight and blister fluid/serum ratio of cytokines and five other molecules evaluated in patients with bullous pemphigoid.
D'Auria L; Pimpinelli F; Ferraro C; D'Ambrogio G; Giacalone B; Bellocci M; Ameglio F
J Biol Regul Homeost Agents; 1998; 12(3):76-80. PubMed ID: 9795835
[TBL] [Abstract][Full Text] [Related]
10. Detection of elevated levels of IL-4, IL-6, and IL-10 in blister fluid of bullous pemphigoid.
Schmidt E; Bastian B; Dummer R; Tony HP; Bröcker EB; Zillikens D
Arch Dermatol Res; 1996 Jun; 288(7):353-7. PubMed ID: 8818181
[TBL] [Abstract][Full Text] [Related]
11. Elevated levels of eotaxin and interleukin-5 in blister fluid of bullous pemphigoid: correlation with tissue eosinophilia.
Wakugawa M; Nakamura K; Hino H; Toyama K; Hattori N; Okochi H; Yamada H; Hirai K; Tamaki K; Furue M
Br J Dermatol; 2000 Jul; 143(1):112-6. PubMed ID: 10886144
[TBL] [Abstract][Full Text] [Related]
12. The interleukin-2 receptor in lesions and serum of bullous pemphigoid.
Zillikens D; Ambach A; Schuessler M; Dummer R; Hartmann AA; Burg G
Arch Dermatol Res; 1992; 284(3):141-5. PubMed ID: 1503497
[TBL] [Abstract][Full Text] [Related]
13. Respective contribution of neutrophil elastase and matrix metalloproteinase 9 in the degradation of BP180 (type XVII collagen) in human bullous pemphigoid.
Verraes S; Hornebeck W; Polette M; Borradori L; Bernard P
J Invest Dermatol; 2001 Nov; 117(5):1091-6. PubMed ID: 11710917
[TBL] [Abstract][Full Text] [Related]
14. Eosinophil-colony stimulating activity in blister fluid of bullous pemphigoid.
Kawachi Y; Otsuka F
J Dermatol Sci; 1997 May; 15(1):51-4. PubMed ID: 9186812
[TBL] [Abstract][Full Text] [Related]
15. High level of thymus and activation-regulated chemokine in blister fluid and sera of patients with bullous pemphigoid.
Kakinuma T; Wakugawa M; Nakamura K; Hino H; Matsushima K; Tamaki K
Br J Dermatol; 2003 Feb; 148(2):203-10. PubMed ID: 12588369
[TBL] [Abstract][Full Text] [Related]
16. Skin-homing interleukin-4 and -13-producing cells contribute to bullous pemphigoid: remission of disease is associated with increased frequency of interleukin-10-producing cells.
Teraki Y; Hotta T; Shiohara T
J Invest Dermatol; 2001 Nov; 117(5):1097-102. PubMed ID: 11710918
[TBL] [Abstract][Full Text] [Related]
17. Increased immunoreactive interleukin-5 levels in blister fluids of bullous pemphigoid.
Endo H; Iwamoto I; Fujita M; Okamoto S; Yoshida S
Arch Dermatol Res; 1992; 284(5):312-4. PubMed ID: 1444583
[No Abstract] [Full Text] [Related]
18. [Leukotriene (LT) B4 and LTC4 in the blister fluid of bullous pemphigoid].
Kawana S; Nishiyama S
Nihon Hifuka Gakkai Zasshi; 1989 May; 99(6):659-64. PubMed ID: 2555604
[TBL] [Abstract][Full Text] [Related]
19. Demonstration of collagenase and elastase activities in the blister fluids from bullous skin diseases. Comparison between dermatitis herpetiformis and bullous pemphigoid.
Oikarinen AI; Zone JJ; Ahmed AR; Kiistala U; Uitto J
J Invest Dermatol; 1983 Sep; 81(3):261-6. PubMed ID: 6309988
[TBL] [Abstract][Full Text] [Related]
20. Increased CCL1 levels in the sera and blister fluid of patients with bullous pemphigoid.
Miyagaki T; Sugaya M; Kagami S; Nakashima H; Ishiura N; Watanabe R; Ohmatsu H; Fujita H; Yazawa N; Kadono T; Fujimoto M; Saeki H; Tamaki K
J Dermatol Sci; 2009 Apr; 54(1):45-7. PubMed ID: 19117730
[No Abstract] [Full Text] [Related]
[Next] [New Search]
